22:43 , Jul 7, 2017 |  BioCentury  |  Finance

Generalists needed

Following a nearly two-year political overhang on the biotech sector, buysiders believe sentiment once again may be turning positive and starting to catch up with the industry’s positive fundamentals. As evidence, they point to the...
23:20 , Apr 7, 2017 |  BioCentury  |  Finance

Taking notice

  Political overhang during the first quarter kept generalists on the sidelines but provided a buying opportunity for life sciences specialists that led the sector to outperform. With “repeal and replace” in the rearview for...
19:30 , Mar 31, 2017 |  BC Week In Review  |  Financial News

Accelerated Pharma amends IPO

On March 28, cancer company Accelerated Pharma Inc. (Westport, Conn.) amended its IPO on NASDAQ and now plans to raise up to $14.4 million through the sale of 2.4 million units at $4-$6. Each unit...
22:15 , Jan 6, 2017 |  BioCentury  |  Finance

Good riddance

  Investors aren’t lamenting the end of 2016, but they are pinned between anxiety and optimism for the year ahead. The anxiety stems from uncertainty about U.S. government policies for healthcare under the new administration....
07:00 , Oct 17, 2016 |  BC Week In Review  |  Financial News

Accelerated Pharma proposes IPO

Accelerated Pharma Inc. , Westport, Conn.   Business: Cancer   Date announced: 2016-10-11   Type: IPO   To be raised: Up to $18.9 million   Shares: 1.9 million   Price: $8-$10   Underwriters: H.C. Wainwright;...